Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Community views on factors affecting medicines resource allocation: cross-sectional survey of 3080 adults in Australia.

Chim L, Salkeld G, Kelly PJ, Lipworth W, Hughes DA, Stockler MR.

Aust Health Rev. 2018 Apr 19. doi: 10.1071/AH16209. [Epub ahead of print]

PMID:
29669674
2.

Qualitative evaluation of evidence-based online decision aid and resources for osteoarthritis management: Understanding patient perspectives.

Jeon YH, Flaherty I, Urban H, Wortley S, Dickson C, Salkeld G, Hunter DJ.

Arthritis Care Res (Hoboken). 2018 Apr 2. doi: 10.1002/acr.23572. [Epub ahead of print]

PMID:
29609208
3.

A trial based economic evaluation of occupational therapy discharge planning for older adults: the HOME randomized trial.

Wales K, Salkeld G, Clemson L, Lannin NA, Gitlin L, Rubenstein L, Howard K, Howell M, Cameron ID.

Clin Rehabil. 2018 Jul;32(7):919-929. doi: 10.1177/0269215518764249. Epub 2018 Mar 23.

PMID:
29569470
4.

Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia.

Chim L, Salkeld G, Kelly P, Lipworth W, Hughes DA, Stockler MR.

PLoS One. 2017 Mar 1;12(3):e0172971. doi: 10.1371/journal.pone.0172971. eCollection 2017.

5.

Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia.

Karikios DJ, Chim L, Martin A, Nagrial A, Howard K, Salkeld G, Stockler MR.

Intern Med J. 2017 Apr;47(4):400-407. doi: 10.1111/imj.13350.

PMID:
27928875
6.

Caveat emptor NICE: biased use of cost-effectiveness is inefficient and inequitable.

Dowie J, Kaltoft MK, Nielsen JB, Salkeld G.

F1000Res. 2015 Oct 16;4:1078. eCollection 2015.

7.

Occupational Therapy Predischarge Home Visits in Acute Hospital Care: A Randomized Trial.

Clemson L, Lannin NA, Wales K, Salkeld G, Rubenstein L, Gitlin L, Barris S, Mackenzie L, Cameron ID.

J Am Geriatr Soc. 2016 Oct;64(10):2019-2026. doi: 10.1111/jgs.14287. Epub 2016 Sep 7.

PMID:
27603152
8.

Personalised Multi-Criterial Online Decision Support for Siblings Considering Stem Cell Donation: An Interactive Aid.

Kaltoft MK, Salkeld G, Dowie J.

Stud Health Technol Inform. 2016;225:1015.

PMID:
27332459
9.

Towards Integrating the Principlist and Casuist Approaches to Ethical Decisions via Multi-Criterial Support.

Kaltoft MK, Nielsen JB, Salkeld G, Dowie J.

Stud Health Technol Inform. 2016;225:540-4.

PMID:
27332259
10.

Valuing the benefits of new anticancer drugs.

Lawrence NJ, Salkeld G, Stockler MR, Karikios D.

Med J Aust. 2016 Jun 20;204(11):403-5. No abstract available.

PMID:
27318395
11.

The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening.

Salkeld G, Cunich M, Dowie J, Howard K, Patel MI, Mann G, Lipworth W.

PLoS One. 2016 Apr 6;11(4):e0152999. doi: 10.1371/journal.pone.0152999. eCollection 2016.

12.

Health Informatics Can Avoid Committing Symbolic Violence by Recognizing and Supporting Generic Decision-making Competencies.

Kaltoft MK, Nielsen JB, Salkeld G, Dowie J.

Stud Health Technol Inform. 2015;218:172-177.

PMID:
26262547
13.

Enhancing Healthcare Provider Feedback and Personal Health Literacy: Dual Use of a Decision Quality Measure.

Kaltoft MK, Nielsen JB, Salkeld G, Dowie J.

Stud Health Technol Inform. 2015;218:74-79.

PMID:
26262530
14.

Developing an Online Decision Aid for Osteoarthritis.

Salkeld G, Wortley S, Hunter D, Umapathy H, Dowie J.

Stud Health Technol Inform. 2015;216:905.

PMID:
26262207
15.

Improving Quality of Life for People with Incurable Large-Bowel Obstruction: Randomized Control Trial of Colonic Stent Insertion.

Young CJ, De-Loyde KJ, Young JM, Solomon MJ, Chew EH, Byrne CM, Salkeld G, Faragher IG.

Dis Colon Rectum. 2015 Sep;58(9):838-49. doi: 10.1097/DCR.0000000000000431.

PMID:
26252845
16.

Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.

Wortley S, Tong A, Lancsar E, Salkeld G, Howard K.

BMC Med Inform Decis Mak. 2015 Jul 14;15:52. doi: 10.1186/s12911-015-0176-0.

17.

Addressing preference heterogeneity in public health policy by combining Cluster Analysis and Multi-Criteria Decision Analysis: Proof of Method.

Kaltoft MK, Turner R, Cunich M, Salkeld G, Nielsen JB, Dowie J.

Health Econ Rev. 2015 May 14;5:10. doi: 10.1186/s13561-015-0048-4. eCollection 2015.

18.

What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders.

Eiring Ø, Landmark BF, Aas E, Salkeld G, Nylenna M, Nytrøen K.

BMJ Open. 2015 Apr 8;5(4):e007848. doi: 10.1136/bmjopen-2015-007848. Review.

19.

Bringing Feedback in From the Outback via a Generic and Preference-Sensitive Instrument for Course Quality Assessment.

Kaltoft MK, Nielsen JB, Salkeld G, Lander J, Dowie J.

JMIR Res Protoc. 2015 Feb 13;4(1):e15. doi: 10.2196/resprot.4012.

20.

Who should decide how much and what information is important in person-centred health care?

Kaltoft MK, Nielsen JB, Salkeld G, Dowie J.

J Health Serv Res Policy. 2015 Jul;20(3):192-5. doi: 10.1177/1355819614567911. Epub 2015 Jan 10.

21.
22.

Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.

Howard K, Salkeld GP, Patel MI, Mann GJ, Pignone MP.

Health Expect. 2015 Dec;18(6):3123-35. doi: 10.1111/hex.12301. Epub 2014 Nov 10.

23.

The threat of human influenza: the viruses, disease impacts, and vaccine solutions.

Yin JK, Salkeld G, Heron L, Khandaker G, Rashid H, Booy R.

Infect Disord Drug Targets. 2014;14(3):150-4. Review.

PMID:
25313099
24.

Enhancing informatics competency under uncertainty at the point of decision: a knowing about knowing vision.

Kaltoft MK, Nielsen JB, Salkeld G, Dowie J.

Stud Health Technol Inform. 2014;205:975-9.

PMID:
25160333
25.

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.

Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, Bennett AA, Briffa T, Bauman A, Martinez C, Wallenhorst C, Lau JK, Brieger DB, Sy RW, Freedman SB.

Thromb Haemost. 2014 Jun;111(6):1167-76. doi: 10.1160/TH14-03-0231. Epub 2014 Apr 1.

PMID:
24687081
26.

Assessing decision quality in patient-centred care requires a preference-sensitive measure.

Kaltoft M, Cunich M, Salkeld G, Dowie J.

J Health Serv Res Policy. 2014 Apr;19(2):110-7. doi: 10.1177/1355819613511076. Epub 2013 Dec 12.

27.

Towards generic online multicriteria decision support in patient-centred health care.

Dowie J, Kjer Kaltoft M, Salkeld G, Cunich M.

Health Expect. 2015 Oct;18(5):689-702. doi: 10.1111/hex.12111. Epub 2013 Aug 2.

28.

Estimates and determinants of economic impacts from influenza-like illnesses caused by respiratory viruses in Australian children attending childcare: a cohort study.

Yin JK, Salkeld G, Lambert SB, Dierig A, Heron L, Leask J, Yui Kwan Chow M, Booy R.

Influenza Other Respir Viruses. 2013 Nov;7(6):1103-12. doi: 10.1111/irv.12138. Epub 2013 Jul 6.

29.

Oseltamivir use in adolescents and adults: clinical and economic considerations.

Yin JK, Heron L, Salkeld G, Rashid H, Booy R.

Infect Disord Drug Targets. 2013 Feb;13(1):53-8. Review.

PMID:
23675927
30.

Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study.

Weber MF, Cunich M, Smith DP, Salkeld G, Sitas F, O'Connell D.

BMC Public Health. 2013 May 3;13:429. doi: 10.1186/1471-2458-13-429.

31.

Enhancing citizen engagement in cancer screening through deliberative democracy.

Rychetnik L, Carter SM, Abelson J, Thornton H, Barratt A, Entwistle VA, Mackenzie G, Salkeld G, Glasziou P.

J Natl Cancer Inst. 2013 Mar 20;105(6):380-6. doi: 10.1093/jnci/djs649. Epub 2013 Feb 1.

PMID:
23378639
32.

Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option.

Flitcroft KL, Irwig LM, Carter SM, Salkeld GP, Gillespie JA.

BMC Gastroenterol. 2012 Dec 29;12:183. doi: 10.1186/1471-230X-12-183. Review.

33.

The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study.

Howard K, Salkeld GP, Mann GJ, Patel MI, Cunich M, Pignone MP.

BMJ Open. 2012 Jan 7;2(1):e000587. doi: 10.1136/bmjopen-2011-000587. Print 2012.

34.

Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment.

Howard K, Salkeld G, Pignone M, Hewett P, Cheung P, Olsen J, Clapton W, Roberts-Thomson IC.

Value Health. 2011 Dec;14(8):1146-52. doi: 10.1016/j.jval.2011.07.012.

35.

How do people with chronic kidney disease value cancer-related quality of life?

Wong G, Howard K, Chapman J, Pollock C, Chadban S, Salkeld G, Tong A, Williams N, Webster A, Craig JC.

Nephrology (Carlton). 2012 Jan;17(1):32-41. doi: 10.1111/j.1440-1797.2011.01531.x.

PMID:
22017753
36.

Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy.

Robertson J, Doran E, Henry DA, Salkeld G.

Health Expect. 2014 Feb;17(1):15-26. doi: 10.1111/j.1369-7625.2011.00715.x. Epub 2011 Aug 12.

37.

Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism.

Yin JK, Wang H, Skinner SR, Salkeld G, Booy R.

Aust N Z J Public Health. 2011 Aug;35(4):393-4. doi: 10.1111/j.1753-6405.2011.00748.x. No abstract available.

PMID:
21806738
38.

Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening.

Cunich M, Salkeld G, Dowie J, Henderson J, Bayram C, Britt H, Howard K.

Patient. 2011;4(3):153-62. doi: 10.2165/11587070-000000000-00000.

PMID:
21766911
39.

Getting evidence into policy: The need for deliberative strategies?

Flitcroft K, Gillespie J, Salkeld G, Carter S, Trevena L.

Soc Sci Med. 2011 Apr;72(7):1039-46. doi: 10.1016/j.socscimed.2011.01.034. Epub 2011 Feb 24.

PMID:
21419539
40.

Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia.

Pignone MP, Flitcroft KL, Howard K, Trevena LJ, Salkeld GP, St John DJ.

Med J Aust. 2011 Feb 21;194(4):180-5.

41.

Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability.

Doran E, Robertson J, Salkeld G.

Aust Health Rev. 2011 Feb;35(1):37-44. doi: 10.1071/AH10902.

PMID:
21367329
42.

Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice?

Flitcroft KL, Salkeld GP, Gillespie JA, Trevena LJ, Irwig LM.

Med J Aust. 2010 Jul 5;193(1):37-42.

PMID:
20618113
43.

Are cancer drugs less likely to be recommended for listing by the Pharmaceutical Benefits Advisory Committee in Australia?

Chim L, Kelly PJ, Salkeld G, Stockler MR.

Pharmacoeconomics. 2010;28(6):463-75. doi: 10.2165/11533000-000000000-00000. Erratum in: Pharmacoeconomics. 2011 Feb 1;29(2):171-2.

PMID:
20465315
44.

Preferences for outcomes of treatment for rectal cancer: patient and clinician utilities and their application in an interactive computer-based decision aid.

Masya LM, Young JM, Solomon MJ, Harrison JD, Dennis RJ, Salkeld GP.

Dis Colon Rectum. 2009 Dec;52(12):1994-2002. doi: 10.1007/DCR.0b013e3181c001b9.

PMID:
19934920
45.

Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.

Howard K, White S, Salkeld G, McDonald S, Craig JC, Chadban S, Cass A.

Value Health. 2010 Mar-Apr;13(2):196-208. doi: 10.1111/j.1524-4733.2009.00668.x. Epub 2009 Oct 29.

46.

The cost-effectiveness of increasing kidney transplantation and home-based dialysis.

Howard K, Salkeld G, White S, McDonald S, Chadban S, Craig JC, Cass A.

Nephrology (Carlton). 2009 Feb;14(1):123-32. doi: 10.1111/j.1440-1797.2008.01073.x.

PMID:
19207859
47.

Implementing patient decision support tools: moving beyond academia?

Harrison JD, Masya L, Butow P, Solomon M, Young J, Salkeld G, Whelan T.

Patient Educ Couns. 2009 Jul;76(1):120-5. doi: 10.1016/j.pec.2008.12.013. Epub 2009 Jan 20.

PMID:
19157763
48.

Communicating about screening.

Entwistle VA, Carter SM, Trevena L, Flitcroft K, Irwig L, McCaffery K, Salkeld G.

BMJ. 2008 Sep 22;337:a1591. doi: 10.1136/bmj.a1591. No abstract available.

PMID:
18809589
49.

Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer.

Howard K, Salkeld G.

Value Health. 2009 Mar-Apr;12(2):354-63. doi: 10.1111/j.1524-4733.2008.00417.x. Epub 2008 Jul 24.

50.

Media influence on Herceptin subsidization in Australia: application of the rule of rescue?

Mackenzie R, Chapman S, Salkeld G, Holding S.

J R Soc Med. 2008 Jun;101(6):305-12. doi: 10.1258/jrsm.2008.070289.

Supplemental Content

Loading ...
Support Center